Clinical Trials
272 trialsEvaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Ottawa Hospital Research Institute
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
M.D. Anderson Cancer Center
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Zhejiang University
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
University of Washington
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Thomas Jefferson University
MCW I-PREDICT
Medical College of Wisconsin
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Hackensack Meridian Health
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
OHSU Knight Cancer Institute
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
M.D. Anderson Cancer Center
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
Massachusetts General Hospital
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Tongji Hospital
MRG003
Sun Yat-sen University
UNC-CAYACC
UNC Lineberger Comprehensive Cancer Center
PROOF
Alliance Foundation Trials, LLC.
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Memorial Sloan Kettering Cancer Center
Prospective Validation of a Points Score System Predicting 30-day Survival
Indiana University
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Vanderbilt-Ingram Cancer Center
Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.
University of Alicante
UNC Metastatic Cancer Radiation Therapy Registry
UNC Lineberger Comprehensive Cancer Center
ESTHER
Dartmouth-Hitchcock Medical Center
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
University of Wisconsin, Madison
REFLECT
University Health Network, Toronto
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
University of Cincinnati
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NRG Oncology
Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer
Roswell Park Cancer Institute
Foley Balloon for Cervical Preparation Before Dilation and Evacuation
Stony Brook University
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
University Health Network, Toronto
MENTOR
Insel Gruppe AG, University Hospital Bern
GRACIE
UNICANCER
SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
ASSIST
Massachusetts General Hospital
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
University of California, Davis
MegaMOST
Centre Leon Berard
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Shandong Cancer Hospital and Institute
Identification of Therapeutic Targets in Metastatic Gastric Cancer
Chinese University of Hong Kong
CER
Cancer Support Community, Research and Training Institute, Philadelphia
ARREST2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
RESTO-IMMUNO
Elsan
FUDOSE
UNICANCER
PR3DICT
Maastricht Radiation Oncology
TRIUMPH
St Vincent's Hospital, Sydney
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Memorial Sloan Kettering Cancer Center
CIME
Centre Leon Berard
GASTIVA
Samsung Medical Center
ECLECTIC
Institut Curie
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
M.D. Anderson Cancer Center
Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors
M.D. Anderson Cancer Center
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center